Reinventing FDA: Bills recently introduced in the Senate and House to
speed up the Food and Drug Administration approval process have a univ
ersally agreed-upon goal: to get effective drugs to patients more quic
kly. But some scientists and patient-advocacy organizations doubt indu
stry representatives' assertion that the two bills will achieve that o
bjective.